Item 5. Other Information
Item 5.
Other Information.
(a)
On October 29, 2025, FDCTech, Inc., a Delaware corporation (“FDCT” or the ““Company”), completed the acquisition
of Alchemy International Ltd., a Seychelles-licensed securities dealer regulated under license number SD136 by the Financial Services
Authority (FSA) (the “Transaction”), pursuant to a Share Purchase Agreement, dated October 29, 2025 (the “Share Purchase
Agreement”). The FSA approved the change of control on October 29, 2025.
Pursuant
to the Share Purchase Agreement, the Company acquired 49,950 of 50,000 issued shares from Sync Capital Limited and Mr. Gope Shyamdas
Kundnani, shareholders of Alchemy International Ltd., effectively assuming full operating control of Alchemy International Ltd. Mr. Kundnani
is the sole beneficial owner of Alchemy International Ltd., holding his interest directly and indirectly through Sync Capital Limited.
The consideration for the transaction is $2,000,000 (the “Purchase Price”), subject to adjustment based on the regulatory
own funds capital at closing. The Purchase Price, payable in cash or in the form of the Company’s capital stock, is due by January
29, 2026.
As
Mr. Gope Shyamdas Kundnani is a member of the Company’s board of directors, the transaction is considered a related party transaction
for the purposes of Item 404(a) of Regulation S-K. The transaction was reviewed, voted upon, and approved by the disinterested board
members prior to execution of the Share Purchase Agreement.
The
foregoing description of the Share Purchase Agreement is not complete and is qualified in its entirety by reference to the full text
of the Share Purchase Agreement, a copy of which is furnished as Exhibit 10.1 to this Quarterly Report on Form 10-Q and is incorporated
by reference.
(b)
There have been no material changes to the procedures by which security holders may recommend nominees to the Company’s Board of
Directors since the Company last provided disclosure in response to the requirements of Item 407(c)(3) of Regulation S-K .
(c)
During the registrant’s last fiscal quarter, no director or officer adopted or terminated : (i) any contract, instruction or written
plan for the purchase or sale of securities of the registrant intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)
(a “Rule 10b5-1 trading arrangement”); and/or (ii) any “non-Rule 10b5-1 trading arrangement” as defined in Item
408(c) of Regulation S-K.
12
Item 6.
Exhibits.
(a)
Exhibits.
Exhibit
Item
10.1
Share Purchase Agreement date as of October 29, 2025
31.1
Certification
of Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
31.2
Certification
of Chief Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
32.1
Certification
of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2
Certification
of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS
Inline
XBRL Instance Document
101.SCH
Inline
XBRL Taxonomy Extension Schema Document
101.CAL
Inline
XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
Inline
XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
Inline
XBRL Taxonomy Extension Label Linkbase Document
101.PRE
Inline
XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover
Page Interactive Data File (embedded within the Inline XBRL document)
13
SIGNATURES
In
accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
FDCTECH, INC.
Date: November 13, 2025
/s/ Mitchell
Eaglstein
Mitchell Eaglstein, President and CEO
(Principal Executive Officer)
Date: November 13, 2025
/s/
Imran Firoz
Imran
Firoz, CFO
(Principal Accounting Officer)
14
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.